IS7076A - Bólusetning með einföldum skammti af Mycoplasma hyopneumoniae, og notkun efnisins í lækningaskyni - Google Patents

Bólusetning með einföldum skammti af Mycoplasma hyopneumoniae, og notkun efnisins í lækningaskyni

Info

Publication number: IS7076A
Authority: IS; Iceland
Prior art keywords: vaccination; drug; single dose; mycoplasma hyopneumoniae; therapeutic use
Prior art date: 2001-07-02

Application number

IS7076A

Other languages

English (en)

Inventor

Lee Keich Robin

Grace Sabbadini Lisa

Original Assignee

Pfizer Products Inc.

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2001-07-02

Filing date

2003-12-15

Publication date

2003-12-15

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=23168589&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=IS7076(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2003-12-15 Application filed by Pfizer Products Inc. filed Critical Pfizer Products Inc.

2003-12-15 Publication of IS7076A publication Critical patent/IS7076A/is

Links

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/0241—Mollicutes, e.g. Mycoplasma, Erysipelothrix
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
- A61K2039/521—Bacterial cells; Fungal cells; Protozoal cells inactivated (killed)
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/53—DNA (RNA) vaccination
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/545—Medicinal preparations containing antigens or antibodies characterised by the dose, timing or administration schedule
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
- A61K2039/552—Veterinary vaccine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55555—Liposomes; Vesicles, e.g. nanoparticles; Spheres, e.g. nanospheres; Polymers
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S435/00—Chemistry: molecular biology and microbiology
- Y10S435/8215—Microorganisms
- Y10S435/822—Microorganisms using bacteria or actinomycetales
- Y10S435/87—Mycoplasma

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
General Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
Chemical & Material Sciences (AREA)
Animal Behavior & Ethology (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Public Health (AREA)
Immunology (AREA)
Epidemiology (AREA)
Microbiology (AREA)
Mycology (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Communicable Diseases (AREA)
Oncology (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Micro-Organisms Or Cultivation Processes Thereof (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)

IS7076A 2001-07-02 2003-12-15 Bólusetning með einföldum skammti af Mycoplasma hyopneumoniae, og notkun efnisins í lækningaskyni IS7076A (is)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US30263601P	2001-07-02	2001-07-02
PCT/IB2002/002121 WO2003003941A2 (en)	2001-07-02	2002-06-07	One dose vaccination with mycoplasma hyopneumoniae

Publications (1)

Publication Number	Publication Date
IS7076A true IS7076A (is)	2003-12-15

Family

ID=23168589

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
IS7076A IS7076A (is)	2001-07-02	2003-12-15	Bólusetning með einföldum skammti af Mycoplasma hyopneumoniae, og notkun efnisins í lækningaskyni

Country Status (42)

Country	Link
US (3)	US6846477B2 (is)
EP (3)	EP2842569B1 (is)
JP (1)	JP2005515162A (is)
KR (1)	KR20040030785A (is)
CN (3)	CN1551781B (is)
AP (1)	AP2003002937A0 (is)
AR (1)	AR034678A1 (is)
AT (1)	ATE412426T2 (is)
AU (1)	AU2002309109B2 (is)
BG (1)	BG66481B1 (is)
BR (1)	BR0210804A (is)
CA (1)	CA2451626C (is)
CY (1)	CY1108749T1 (is)
CZ (1)	CZ305781B6 (is)
DE (1)	DE60229666D1 (is)
DK (3)	DK1474067T4 (is)
DO (1)	DOP2002000431A (is)
EA (1)	EA009901B1 (is)
ES (3)	ES2550458T3 (is)
GT (1)	GT200200138A (is)
HK (1)	HK1207584A1 (is)
HR (1)	HRP20031079A2 (is)
HU (1)	HU230246B1 (is)
IL (1)	IL159349A0 (is)
IS (1)	IS7076A (is)
MA (1)	MA27047A1 (is)
MX (1)	MXPA03011599A (is)
NO (1)	NO342654B1 (is)
NZ (1)	NZ530106A (is)
OA (1)	OA12638A (is)
PA (1)	PA8549701A1 (is)
PE (1)	PE20030285A1 (is)
PL (1)	PL209773B1 (is)
PT (3)	PT2027873E (is)
SK (1)	SK288010B6 (is)
TN (1)	TNSN03155A1 (is)
TW (1)	TWI329514B (is)
UA (1)	UA78707C2 (is)
UY (1)	UY27366A1 (is)
WO (1)	WO2003003941A2 (is)
YU (1)	YU102203A (is)
ZA (1)	ZA200309698B (is)

Families Citing this family (52)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
MY129765A (en) *	2000-12-19	2007-04-30	Wyeth Corp	Improved mycoplasma hyopneumoniae bacterin vaccine
WO2006056841A1 (en) *	2004-11-24	2006-06-01	Pharmacia & Upjohn Company Llc	Multiple-strain mycoplasma hyopneumoniae vaccines
US7833707B2 (en)	2004-12-30	2010-11-16	Boehringer Ingelheim Vetmedica, Inc.	Methods of overexpression and recovery of porcine circovirus type 2 ORF2
US7700285B1 (en)	2005-12-29	2010-04-20	Boehringer Ingelheim Vetmedica, Inc.	PCV2 immunogenic compositions and methods of producing such compositions
UA95602C2 (ru)	2004-12-30	2011-08-25	Берингер Ингельхейм Ветмедика, Инк.	Иммуногенная композиция цвс2 и способы приготовления такой композиции
US8834891B2 (en)	2005-03-14	2014-09-16	Boehringer Ingelheim Vetmedica, Inc.	Immunogenic compositions comprising Lawsonia intracellularis
EP1968630B1 (en)	2005-12-29	2018-01-24	Boehringer Ingelheim Vetmedica, Inc.	Multivalent pcv2 immunogenic compositions
MX338626B (es)	2005-12-29	2016-04-26	Boehringer Ingelheim Vetmed	Uso de una composicion inmunogenica de pcv2 para producir los sintomas clinicos en cerdos.
EP1991262A4 (en) *	2006-03-03	2009-11-04	Merial Ltd	MYCOPLASMA HYOPNEUMONIAE VACCINE
EP2099927A4 (en) *	2006-11-22	2010-05-05	Boehringer Ingelheim Vetmed	Methods of reducing porcine circovirus-associated disease outbreaks
EP2859900A1 (en) *	2006-12-11	2015-04-15	Boehringer Ingelheim Vetmedica, Inc.	Effective method of treatment of porcine circovirus and lawsonia intracellularis infections
JP5200223B2 (ja)	2006-12-15	2013-06-05	ベーリンガーインゲルハイムフェトメディカインコーポレイテッド	Ｐｃｖ２抗原によるブタの処置
EP1941903A1 (en)	2007-01-03	2008-07-09	Boehringer Ingelheim Vetmedica Gmbh	Prophylaxis and treatment of PRDC
EP1958644A1 (en)	2007-02-13	2008-08-20	Boehringer Ingelheim Vetmedica Gmbh	Prevention and treatment of sub-clinical pcvd
US7829274B2 (en)	2007-09-04	2010-11-09	Boehringer Ingelheim Vetmedica, Inc.	Reduction of concomitant infections in pigs by the use of PCV2 antigen
UA98812C2 (ru) *	2007-11-06	2012-06-25	Вайет Ллк	Авирулентная активированная живая вакцина mycoplasma hyopneumoniae
WO2009088950A2 (en) *	2007-12-31	2009-07-16	Boehringer Ingelheim Vetmedica, Inc.	Pcv2 orf2 virus like particle with foreign amino acid insertion
CN101236206B (zh) *	2008-01-17	2014-10-15	中国兽医药品监察所	一种猪肺炎支原体重组抗原elisa检测试剂盒
KR20100113582A (ko) *	2008-01-23	2010-10-21	베링거잉겔하임베트메디카인코퍼레이티드	Ｐｃｖ2 마이코플라즈마 히오뉴모니에 면역원성 조성물 및 당해 조성물의 생산 방법
US8444989B1 (en) *	2008-04-18	2013-05-21	Boehringer Ingelheim Vetmedica Gmbh	One dose vaccination against mycoplasma infections of pigs
ES2569907T3 (es) *	2008-06-27	2016-05-13	Zoetis Services Llc	Composiciones adyuvantes novedosas
KR101795524B1 (ko)	2009-06-04	2017-11-08	고쿠리츠칸센쇼켄쿠죠	마이코플라즈마 감염증용 백신
AR078253A1 (es)	2009-09-02	2011-10-26	Boehringer Ingelheim Vetmed	Metodos para reducir la actividad antivirica en composiciones pcv-2 y composiciones pcv-2 con mejor inmunogenicidad
AU2011230619C1 (en)	2010-03-25	2016-06-23	Oregon Health & Science University	CMV glycoproteins and recombinant vectors
PL2569007T3 (pl)	2010-05-11	2016-04-29	Intervet Int Bv	Szczepionka przeciwko Mycoplasma Hyopneumoniae, odpowiednia do podawania w obecności przeciwciał pochodzących od matki
SG187201A1 (en) *	2010-07-26	2013-02-28	Qu Biolog Inc	Immunogenic anti-inflammatory compositions
US8546149B2 (en)	2010-08-27	2013-10-01	Intervet Inc.	Potency test for vaccine formulations
HUE028877T2 (en) *	2010-08-27	2017-01-30	Intervet Int Bv	Test of biological activity of vaccine formulation
HUE037408T2 (hu)	2011-06-10	2018-08-28	Univ Oregon Health & Science	CMV glikoproteinek és rekombináns vektorok
UA115053C2 (uk)	2012-03-07	2017-09-11	Сева Санте Анімаль	Композиція, що містить антиген і ліпополісахарид у формі масло-в-воді, та спосіб її використання (варіанти)
US9120859B2 (en)	2012-04-04	2015-09-01	Zoetis Services Llc	Mycoplasma hyopneumoniae vaccine
UA114504C2 (uk)	2012-04-04	2017-06-26	Зоетіс Сервісіз Ллс	Комбінована вакцина pcv, mycoplasma hyopneumoniae та prrs
UA114503C2 (uk)	2012-04-04	2017-06-26	Зоетіс Сервісіз Ллс	Комбінована вакцина pcv та mycoplasma hyopneumoniae
SG11201505086QA (en)	2012-12-28	2015-07-30	Boehringer Ingelheim Vetmed	Immunogenic composition comprising mycoplasma antigens
PT2938747T (pt)	2012-12-28	2019-08-01	Boehringer Ingelheim Vetmedica Gmbh	Método de preparação de uma vacina de micoplasma
EP2955192B1 (en) *	2013-02-05	2020-07-01	Agricultural Technology Research Institute	Anti-mycoplasma spp. subunit vaccine
CN104338125A (zh) *	2013-07-29	2015-02-11	普莱柯生物工程股份有限公司	一种猪肺炎支原体抗原在预防和治疗猪呼吸道疾病综合征方面的应用
UA130246C2 (uk)	2013-09-19	2025-12-31	Зоетіс Сервісіз Ллс	Ад'ювант на основі олії
US9505808B2 (en)	2013-10-02	2016-11-29	Boehringer Ingelheim Vetmedica, Inc.	PCV2 ORF2 protein variant and virus like particles composed thereof
CN105792841B (zh) *	2013-11-21	2019-07-26	财团法人农业科技研究院	防治霉浆菌感染的组合物
CN105012948B (zh) *	2014-04-18	2019-07-30	普莱柯生物工程股份有限公司	一种疫苗组合物及其应用
CN104248753B (zh) *	2014-05-15	2017-07-28	普莱柯生物工程股份有限公司	一种疫苗组合物及其应用
BR102014014727B1 (pt) *	2014-06-16	2018-04-03	Ouro Fino Saúde Animal Ltda	COMPLEXO DE POLIPROTEÍNAS IMUNOGÊNICAS DE M. hyopneumoniae, GENE SINTÉTICO CODIFICANTE DO COMPLEXO DE POLIPROTEÍNAS IMUNOGÊNICAS DE M. hyopneumoniae, COMPOSIÇÃO ANTIGÊNICA, PROCESSO DE OBTENÇÃO DE UM COMPLEXO DE POLIPROTEÍNAS IMUNOGÊNICAS DE M. hyopneumoniae
US9814769B2 (en)	2014-09-30	2017-11-14	Qatar University	Vaccines against pathogenic Escherichia coli and methods of using the same
CN115317600A (zh)	2015-01-16	2022-11-11	硕腾服务有限责任公司	口蹄疫疫苗
KR20160099223A (ko) *	2015-02-12	2016-08-22	강원대학교산학협력단	마이코플라스마 하이오뉴모니애 박테린 백신 및 이의 제조방법
EP3498847A4 (en) *	2016-08-12	2020-03-04	Innovac	VACCINE COMPOSITION FOR PREVENTING PORCINE MYCOPLASMA INFECTIONS WITH RECOMBINANT PROTEIN
RU2668799C1 (ru) *	2017-09-08	2018-10-02	Эгрикалчурал Текнолоджи Рисерч Инститьют	Субъединичная вакцина против mycoplasma spp.
CN108101969A (zh) *	2017-11-13	2018-06-01	南京大爻网络科技有限公司	一种与猪支原体肺炎相关的抗原及其应用
RU2695679C1 (ru) *	2018-09-11	2019-07-25	Эгрикалчурал Текнолоджи Рисерч Инститьют	Субъединичная вакцина против mycoplasma spp.
RU2759427C2 (ru) *	2019-07-08	2021-11-12	Эгрикалчурал Текнолоджи Рисерч Инститьют	Субъединичная вакцина против mycoplasma spp
CN117305192A (zh) *	2023-12-01	2023-12-29	北京瑞阳瑞泰生物科技有限公司	一种猪肺炎支原体rt02株、疫苗组合物及其应用

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP0283840A3 (en) *	1987-03-26	1989-08-09	Ml Technology Ventures, L.P.	Mycoplasma hyopneumoniae antigen and uses therefor
US5252328A (en) *	1987-03-26	1993-10-12	Martin Marietta Energy Systems, Inc.	Mycoplasma hyopneumoniae antigen and uses therefor
ES2058237T3 (es)	1987-09-18	1994-11-01	Akzo Nv	Metodo para la preparacion de una vacuna para combatir la infeccion mycoplasmica en aves de corral.
JPH05506984A (ja)	1990-04-02	1993-10-14	サイナーゲン，インコーポレーテッド	動物におけるマイコプラズマ感染に対する診断と治療に有用なポリペプチド
US6113916A (en) *	1990-05-29	2000-09-05	American Cyanamid Company	Method of enhancing cell mediated immune responses
CA2082155C (en)	1990-05-29	2008-04-15	Krishnaswamy I. Dayalu	Swine pneumonia vaccine and method of preparation
US5565205A (en) *	1990-08-16	1996-10-15	Solvay Animal Health, Inc.	Inactivated Mycoplasma hypopneumoniae bacterin and method of use thereof
EP0475185A1 (en)	1990-08-27	1992-03-18	Nippon Flour Mills Co., Ltd.	DNA's encoding surface antigen of mycoplasma hyopneumoniae, DNA fragments for primer, recombinant antigenic peptides and diagnostic method of mycoplasmal pneumoniae of swine using same
US5338543A (en) *	1992-02-27	1994-08-16	Ambico, Inc.	Thimerosal inactivated mycoplasma hyopneumoniae vaccine
DE69333588T2 (de) *	1992-09-28	2005-08-04	Wyeth Holdings Corp.	Verfahren zur verstärkung zellularer immunantworten
US5530874A (en)	1993-02-02	1996-06-25	3Com Corporation	Network adapter with an indication signal mask and an interrupt signal mask
WO1995009870A1 (en)	1993-10-07	1995-04-13	Iowa State University Research Foundation, Inc.	Characterization of mycoplasma hyopneumoniae adhesins
PT759780E (pt)	1994-05-10	2001-01-31	American Home Prod	Vacina melhorada de vsrb vivo modificado
US5788962A (en)	1995-01-17	1998-08-04	The Curators Of The University Of Missouri	DNA sequences coding for mycoplasma hyopneumoniae surface antigens, corresponding proteins and use in vaccines and diagnostic procedures
AUPN178995A0 (en)	1995-03-16	1995-04-13	University Of Melbourne, The	Antigen composition
ATE272409T1 (de)	1996-09-30	2004-08-15	Univ Arkansas	Verfahren zur erzeugung aktiver immunität durch vakzinkonjugate
EP0846468B1 (en)	1996-12-05	2004-06-09	Akzo Nobel N.V.	Non-virulent mycoplasma synoviae and vaccine thereof
CA2311759A1 (en)	1997-11-26	1999-06-03	Tsungdas Hsu	Recombinant mycoplasma hyopneumoniae vaccine
AU6128900A (en) *	1999-09-29	2001-04-05	Pfizer Products Inc.	Nucleic acids and proteins of the mycoplasma hyopneumoniae mph3 gene and uses thereof
US6585981B1 (en) *	2000-07-27	2003-07-01	Regents Of The University Of Minnesota	Temperature-sensitive live vaccine for Mycoplasma hyopneumoniae
UA114504C2 (uk)	2012-04-04	2017-06-26	Зоетіс Сервісіз Ллс	Комбінована вакцина pcv, mycoplasma hyopneumoniae та prrs

2002
- 2002-06-07 WO PCT/IB2002/002121 patent/WO2003003941A2/en not_active Ceased
- 2002-06-07 BR BR0210804-6A patent/BR0210804A/pt not_active Application Discontinuation
- 2002-06-07 ES ES08167761.9T patent/ES2550458T3/es not_active Expired - Lifetime
- 2002-06-07 KR KR10-2004-7000044A patent/KR20040030785A/ko not_active Ceased
- 2002-06-07 EP EP14182639.6A patent/EP2842569B1/en not_active Revoked
- 2002-06-07 YU YU102203A patent/YU102203A/sh unknown
- 2002-06-07 ES ES14182639T patent/ES2729579T3/es not_active Expired - Lifetime
- 2002-06-07 AP APAP/P/2003/002937A patent/AP2003002937A0/en unknown
- 2002-06-07 DE DE60229666T patent/DE60229666D1/de not_active Expired - Lifetime
- 2002-06-07 AU AU2002309109A patent/AU2002309109B2/en not_active Expired
- 2002-06-07 JP JP2003509957A patent/JP2005515162A/ja active Pending
- 2002-06-07 HR HR20031079A patent/HRP20031079A2/hr not_active Application Discontinuation
- 2002-06-07 EP EP02735755.7A patent/EP1474067B2/en not_active Expired - Lifetime
- 2002-06-07 PL PL373367A patent/PL209773B1/pl unknown
- 2002-06-07 PT PT81677619T patent/PT2027873E/pt unknown
- 2002-06-07 ES ES02735755.7T patent/ES2312580T5/es not_active Expired - Lifetime
- 2002-06-07 PT PT14182639T patent/PT2842569T/pt unknown
- 2002-06-07 SK SK1579-2003A patent/SK288010B6/sk unknown
- 2002-06-07 CZ CZ2003-3466A patent/CZ305781B6/cs not_active IP Right Cessation
- 2002-06-07 MX MXPA03011599A patent/MXPA03011599A/es active IP Right Grant
- 2002-06-07 DK DK02735755.7T patent/DK1474067T4/en active
- 2002-06-07 HU HU0400434A patent/HU230246B1/hu unknown
- 2002-06-07 EA EA200301323A patent/EA009901B1/ru not_active IP Right Cessation
- 2002-06-07 NZ NZ530106A patent/NZ530106A/en not_active IP Right Cessation
- 2002-06-07 DK DK08167761.9T patent/DK2027873T3/en active
- 2002-06-07 OA OA1200300344A patent/OA12638A/en unknown
- 2002-06-07 CA CA2451626A patent/CA2451626C/en not_active Expired - Lifetime
- 2002-06-07 PT PT02735755T patent/PT1474067E/pt unknown
- 2002-06-07 CN CN028133447A patent/CN1551781B/zh not_active Expired - Lifetime
- 2002-06-07 DK DK14182639.6T patent/DK2842569T3/da active
- 2002-06-07 CN CN201210389058.0A patent/CN102872456B/zh not_active Expired - Lifetime
- 2002-06-07 AT AT02735755T patent/ATE412426T2/de active
- 2002-06-07 EP EP08167761.9A patent/EP2027873B8/en not_active Expired - Lifetime
- 2002-06-07 CN CN200810186079.6A patent/CN101524532B/zh not_active Expired - Lifetime
- 2002-06-07 IL IL15934902A patent/IL159349A0/xx unknown
- 2002-06-07 TN TNPCT/IB2002/002121A patent/TNSN03155A1/fr unknown
- 2002-06-19 US US10/174,701 patent/US6846477B2/en not_active Ceased
- 2002-06-26 TW TW091114057A patent/TWI329514B/zh not_active IP Right Cessation
- 2002-06-26 DO DO2002000431A patent/DOP2002000431A/es unknown
- 2002-07-01 UY UY27366A patent/UY27366A1/es not_active Application Discontinuation
- 2002-07-01 PE PE2002000593A patent/PE20030285A1/es not_active Application Discontinuation
- 2002-07-01 AR ARP020102479A patent/AR034678A1/es not_active Application Discontinuation
- 2002-07-02 GT GT200200138A patent/GT200200138A/es unknown
- 2002-07-02 PA PA20028549701A patent/PA8549701A1/es unknown
- 2002-07-06 UA UA20031213200A patent/UA78707C2/uk unknown
2003
- 2003-12-12 ZA ZA2003/09698A patent/ZA200309698B/en unknown
- 2003-12-15 IS IS7076A patent/IS7076A/is unknown
- 2003-12-22 NO NO20035762A patent/NO342654B1/no not_active IP Right Cessation
- 2003-12-31 MA MA27468A patent/MA27047A1/fr unknown
2004
- 2004-01-26 BG BG108546A patent/BG66481B1/bg unknown
- 2004-08-12 US US10/917,130 patent/US20050013823A1/en not_active Abandoned
2009
- 2009-01-16 CY CY20091100059T patent/CY1108749T1/el unknown
2012
- 2012-03-02 US US13/411,232 patent/USRE44399E1/en not_active Expired - Lifetime
2015
- 2015-08-27 HK HK15108334.1A patent/HK1207584A1/en unknown

Also Published As

Publication number	Publication date
PL209773B1 (pl)	2011-10-31
NO342654B1 (no)	2018-06-25
EP1474067A4 (en)	2005-08-10
EP2842569A1 (en)	2015-03-04
EP1474067A2 (en)	2004-11-10
EA200301323A1 (ru)	2005-06-30
GT200200138A (es)	2003-05-15
EP2027873B8 (en)	2015-11-11
NZ530106A (en)	2007-06-29
BR0210804A (pt)	2005-05-03
DK1474067T3 (da)	2008-12-08
EP1474067B1 (en)	2008-10-29
AP2003002937A0 (en)	2003-12-31
PT1474067E (pt)	2008-11-14
ES2312580T3 (es)	2009-03-01
CZ305781B6 (cs)	2016-03-16
DOP2002000431A (es)	2003-01-15
TWI329514B (en)	2010-09-01
MXPA03011599A (es)	2005-03-07
SK288010B6 (sk)	2012-10-02
CZ20033466A3 (cs)	2005-06-15
PE20030285A1 (es)	2003-03-27
HUP0400434A2 (en)	2007-08-28
HK1134900A1 (zh)	2010-05-20
CA2451626C (en)	2011-05-31
EP2027873A1 (en)	2009-02-25
TNSN03155A1 (fr)	2005-12-23
EP2842569B1 (en)	2019-04-10
CY1108749T1 (el)	2014-04-09
MA27047A1 (fr)	2004-12-20
HU230246B1 (hu)	2015-11-30
AR034678A1 (es)	2004-03-03
OA12638A (en)	2006-06-15
CN101524532A (zh)	2009-09-09
KR20040030785A (ko)	2004-04-09
ES2550458T3 (es)	2015-11-10
CN1551781B (zh)	2013-01-02
ZA200309698B (en)	2014-04-30
HK1068250A1 (en)	2005-04-29
DE60229666D1 (de)	2008-12-11
UA78707C2 (en)	2007-04-25
HRP20031079A2 (en)	2005-10-31
ES2312580T5 (es)	2017-12-11
US20050013823A1 (en)	2005-01-20
PA8549701A1 (es)	2003-01-24
CN101524532B (zh)	2014-03-19
WO2003003941A2 (en)	2003-01-16
BG66481B1 (bg)	2015-02-27
HK1207584A1 (en)	2016-02-05
EP1474067B2 (en)	2017-08-16
EP2027873B1 (en)	2015-09-09
JP2005515162A (ja)	2005-05-26
PT2027873E (pt)	2015-11-03
US20030109473A1 (en)	2003-06-12
HK1180224A1 (zh)	2013-10-18
UY27366A1 (es)	2003-04-30
CN102872456A (zh)	2013-01-16
WO2003003941A3 (en)	2004-07-29
CN1551781A (zh)	2004-12-01
ES2729579T3 (es)	2019-11-04
SK15792003A3 (sk)	2005-09-08
AU2002309109B2 (en)	2007-12-13
DK2842569T3 (da)	2019-05-20
DK2027873T3 (en)	2015-11-09
NO20035762L (no)	2004-02-02
IL159349A0 (en)	2004-06-01
USRE44399E1 (en)	2013-07-30
PT2842569T (pt)	2019-06-17
EA009901B1 (ru)	2008-04-28
BG108546A (bg)	2005-02-28
PL373367A1 (en)	2005-08-22
US6846477B2 (en)	2005-01-25
YU102203A (sh)	2006-05-25
CN102872456B (zh)	2016-01-20
DK1474067T4 (en)	2017-10-16
CA2451626A1 (en)	2003-01-16
ATE412426T2 (de)	2008-11-15

Publication	Publication Date	Title
IS7076A (is)	2003-12-15	Bólusetning með einföldum skammti af Mycoplasma hyopneumoniae, og notkun efnisins í lækningaskyni
NO20053224D0 (no)	2005-07-01	Patient controlled drug administration device.
ATE282428T1 (de)	2004-12-15	Pharmazeutische dosierungsform von amorphem nilfenavir mesylat
NO20035298D0 (no)	2003-11-28	CDK-inhiberende pyrimider, deres fremstilling og deres anvendelse som legemidler
PT1605956E (pt)	2016-03-09	Administração de capsaicinóides para o tratamento da osteoartrite
NO20035773L (no)	2004-02-27	Ny konstruert superantigen for human terapi
IS7691A (is)	2005-02-09	Lyfjasamsetningar til að meðhöndla æxli
EE05581B1 (et)	2012-10-15	Aripiprasooli ravimlahus peroraalseks manustamiseks
IS8398A (is)	2006-04-05	Lyfjasamsetningar til að meðhöndla æxli
DE60308372D1 (de)	2006-10-26	Dosierungsverabreichungsvorrichtung
EP1383518A4 (en)	2005-11-09	ORAL DELIVERY OF MACROMOLECULES
IL165860A0 (en)	2006-01-15	Administration of therapeutic viruses
DK1537096T3 (da)	2009-02-02	Derivater af dioxan-2-alkylcarbamater, fremstilling og terapeutisk anvendelse heraf
EP1423141A4 (en)	2005-08-03	VACCINE
IS7065A (is)	2003-12-05	Áætlun um lyfjaskammta við meðferð og lyfjasamsetningar til getnaðarvarna í neyð
DK1513835T3 (da)	2006-12-27	Piperazinylacylpiperidinderivater, fremstilling og terapeutisk anvendelse heraf
DK1590321T3 (da)	2010-08-09	Arylalkylcarbamat-derivater, fremstilling og terapeutisk anvendelse deraf
DK1417189T3 (da)	2006-05-08	Acylaminothiazolderivater, fremstilling og terapeutisk anvendelse heraf
DK1525193T3 (da)	2008-04-28	Acylaminothiazolderivater, deres fremstilling og deres terapeutiske anvendelse
DK1387838T3 (da)	2006-08-14	Cyanoanthranylamid-derivater og deres anvendelse som lægemidler
DK1556382T3 (da)	2008-10-06	3-Phenylpyridoindolderivater, fremstilling og terapeutisk anvendelse deraf
EE200300501A (et)	2003-12-15	Ninna manustatavad imidasotriasinooni sisaldavad kompositsioonid
DE60336999D1 (de)	2011-06-16	Melatonin enthaltende pharmazeutische formulierung
NO20033120D0 (no)	2003-07-08	2-arylimino-2,3-dihydrotiazolderivater, fremgangsmater for fremstilling derav og terapeutisk anvendelse derav
FR2820311B3 (fr)	2003-01-17	Distributeur de medicament portatif